Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT-Reference-Cited by-同舟云学术

Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT

Published:2008-04 Issue:1 Volume:247 Page:189-196
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Tateishi Ukihide,Gamez Cristina,Dawood Shaheenah,Yeung Henry W. D.,Cristofanilli Massimo,Macapinlac Homer A.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2471070567

Reference24 articles.

1. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

2. SmithIC, Welch AE, Hutcheon AW, et al. Positron emission tomography using [(18)F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy.J Clin Oncol2000;18(8):1676–1688.

3. SchellingM, Avril N, Nahrig J, et al. Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.J Clin Oncol2000;18(8):1689–1695.

4. Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy

5. Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines;The Breast;2024-09

2. The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-07

3. A bibliometric analysis based on hotspots and frontier trends of positron emission tomography/computed tomography utility in bone and soft tissue sarcoma;Frontiers in Oncology;2024-06-21

4. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

5. Bone Metastases;The Cancer Journal;2024-05